Browsing: biotechnology

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A Food and Drug Administration advisory panel on Wednesday endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer, concluding that the benefits of the test outweighed its risks.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

In late August, the Food and Drug Administration approved a new therapeutic for pancreatic cancer, daraxonrasib, developed by Revolution Medicines. This drug is for previously treated patients and represents a revolutionary new therapeutic to target KRAS inside pancreatic cancers, the most commonly mutated oncogene found in the disease. Having this mutation is a very bad…

Drugs called orexin agonists have been hailed for their ability to treat rare sleep disorders, but with new data, Alkermes is showing for the first time that the new class of therapies may benefit people with ADHD.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Shares in Grail, the company developing a blood test aimed at detecting many different types of cancer early, when they can be treated more effectively, surged 33% Monday after the Food and Drug Administration posted documents ahead of an advisory committee meeting that suggest the agency may take a favorable view of the test.

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.